HomeCompareCUCSY vs JNJ

CUCSY vs JNJ: Dividend Comparison 2026

CUCSY yields 5.37% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CUCSY wins by $668.1K in total portfolio value
10 years
CUCSY
CUCSY
● Live price
5.37%
Share price
$14.20
Annual div
$0.76
5Y div CAGR
48.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$698.4K
Annual income
$405,515.83
Full CUCSY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CUCSY vs JNJ

📍 CUCSY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCUCSYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CUCSY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CUCSY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CUCSY
Annual income on $10K today (after 15% tax)
$456.04/yr
After 10yr DRIP, annual income (after tax)
$344,688.46/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CUCSY beats the other by $340,702.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CUCSY + JNJ for your $10,000?

CUCSY: 50%JNJ: 50%
100% JNJ50/50100% CUCSY
Portfolio after 10yr
$364.3K
Annual income
$205,102.62/yr
Blended yield
56.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CUCSY
No analyst data
Altman Z
2.9
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CUCSY buys
0
JNJ buys
0
No recent congressional trades found for CUCSY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCUCSYJNJ
Forward yield5.37%2.13%
Annual dividend / share$0.76$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR48.1%28%
Portfolio after 10y$698.4K$30.3K
Annual income after 10y$405,515.83$4,689.40
Total dividends collected$645.3K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CUCSY vs JNJ ($10,000, DRIP)

YearCUCSY PortfolioCUCSY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,495$794.59$10,592$272.30+$903.00CUCSY
2$13,563$1,264.17$11,289$357.73+$2.3KCUCSY
3$16,577$2,064.68$12,123$472.89+$4.5KCUCSY
4$21,231$3,492.81$13,141$629.86+$8.1KCUCSY
5$28,908$6,191.44$14,408$846.81+$14.5KCUCSY
6$42,601$11,668.67$16,021$1,151.60+$26.6KCUCSY
7$69,383$23,800.44$18,122$1,588.22+$51.3KCUCSY
8$127,893$53,653.03$20,930$2,228.20+$107.0KCUCSY
9$273,731$136,885.86$24,792$3,191.91+$248.9KCUCSY
10$698,408$405,515.83$30,274$4,689.40+$668.1KCUCSY

CUCSY vs JNJ: Complete Analysis 2026

CUCSYStock

China Communications Services Corporation Limited provides telecommunications support services worldwide. It offers telecommunications infrastructure services, including planning, design, construction, and project supervision for fixedline, mobile, broadband networks, data centers and supporting systems; construction services of ancillary communications networks; and integrated solutions for informatization, as well as intelligentization solutions of industries. The company also provides business process outsourcing services comprising network maintenance and optimization services that include fiber optic and electric cables, mobile base stations, network equipment, and terminals; property management services for customers data centers, cloud computing bases, commercial and residential buildings, high-speed railway stations, airports, etc.; and supply chain services, including logistics and transportation, warehousing and distribution, inspection service and tender agent, digital procurement, repair and disposition to domestic telecommunications operators, government, and enterprises customers. In addition, it offers applications, content, and other services, such as system integration, software development and system support, value-added, and other services. Further, the company provides submarine cable installation and other related services. Additionally, it involved in the distribution of communication products; terminals sales; device distribution services; and distribution and procurement services of IT devices, auxiliary machinery, and equipment. It serves telecommunications operators; and non-telecom operator customers, such as government, construction, transportation, power, and financial institutions, as well as overseas customers. The company was incorporated in 2006 and is headquartered in Beijing, China. China Communications Services Corporation Limited is a subsidiary of China Telecommunications Corporation.

Full CUCSY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CUCSY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CUCSY vs SCHDCUCSY vs JEPICUCSY vs OCUCSY vs KOCUCSY vs MAINCUCSY vs ABBVCUCSY vs MRKCUCSY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.